Skip to content

Effect of Instrument-assisted Soft Tissue Mobilization on Functional and Cognitive Abilities in Elderly

Effect of Instrument-assisted Soft Tissue Mobilization on Functional and Cognitive Abilities in Elderly

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07208630
Acronym
IASTM-AGE
Enrollment
60
Registered
2025-10-06
Start date
2025-10-03
Completion date
2026-03-01
Last updated
2026-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional Abilities, Cognitive Abilities

Brief summary

PURPOSE: To determine the effect of Instrument-assisted soft tissue mobilization on functional and cognitive abilities in elderly. BACKGROUND: There is an increased interest in health care with growth of the older population. Instrument-Assisted Soft Tissue Mobilization (IASTM) is a manual therapy technique using specially designed tools to apply pressure and mobilize soft tissues. It has gained attention as a non-invasive intervention that can aid in improving musculoskeletal health and overall function, especially in older adults. Given the aging population and the rise in age-related functional and cognitive decline, there is a pressing need for effective strategies to enhance quality of life in this demographic. In the elderly, musculoskeletal issues, such as reduced muscle flexibility, joint stiffness, and soft tissue restrictions, are common and can severely impact physical function. IASTM has been shown to increase tissue perfusion, reduce fascial restrictions, and improve joint mobility. These effects are critical in countering age-related declines in mobility, balance, and overall physical functionality, ultimately promoting greater independence and reducing fall risk. Improved physical function through IASTM may also influence cognitive health positively, as increased physical activity and mobility are linked to better cognitive outcomes in the elderly. HYPOTHESES: There will be no significant effect of Instrument-assisted soft tissue mobilization on functional and cognitive abilities in elderly. RESEARCH QUESTION: Does instrument-assisted soft tissue mobilization is effective on functional and cognitive abilities in elderly?

Interventions

IASTM will be delivered using stainless-steel instruments with beveled edges, applied to the target muscle groups for approximately 20 minutes per session, two times per week, over four weeks. A licensed physical therapist trained in IASTM will perform the procedure. Lubricant will be applied to the skin, and strokes will be delivered in multiple directions with pressure adapted to patient tolerance.

BEHAVIORALTraditional physical therapy

The control group will receive a traditional physical therapy program focusing on strength, balance, flexibility, and functional mobility training, combined with simple cognitive stimulation tasks. Sessions will last 30 minutes, two times per week, for four weeks, supervised by a licensed physical therapist.

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
65 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* 60 elderly subjects aged range from 65-75 years old will participant in the study from both genders. * had cognitive abilities to understand explanations and instructions * did not take any medication that can affect their balance.

Exclusion criteria

* They neither had sever musculoskeletal disorders * Nor neurological damage related to balance (dizziness, vestibular dysfunction) * Nor orthostatic hypotension * Nor health risk factors.

Design outcomes

Primary

MeasureTime frameDescription
Change in Short Physical Performance Battery (SPPB) scoreBaseline and 4 weeks (end of treatment).Mean change in SPPB total score (0-12; higher = better physical function) from baseline to end of intervention. The SPPB includes standing balance, 4-m gait speed, and five-times-sit-to-stand.

Secondary

MeasureTime frameDescription
Change in Montreal Cognitive Assessment (MoCA) scoreBaseline and 4 weeks (end of treatment).Mean change in MoCA total score (0-30; higher = better cognition) from baseline to end of intervention and at follow-up.

Countries

Egypt

Contacts

CONTACTNouran Ahmed Ibrahim, lecturer
nouran-312@cu.edu.eg+201062207203

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 25, 2026